Tags : Multi-Project

PhoreMost Signs Multi-Project Drug Discovery Collaboration with Otsuka Pharmaceutical to

Shots: The companies collaborated to identify targets for Otsuka’s therapeutics discovery programmes by leveraging PhoreMost’s expertise and next-generation phenotypic screening platform, SITESEEKER Otsuka will validate the novel targets identified in the collaboration as part of its internal development pipeline with an initial focus on gene therapy applications of identified targets  PhoreMost’s SITESEEKER platform deploys protein […]Read More

PhoreMost Signs a Multi-Project Drug Discovery Agreement with Boehringer Ingelheim

Shots: PhoreMost to receive upfront and research funding plus milestones and will utilize its expertise and phenotypic screening platform, SITESEEKER for the targets identified by BI and will be further included in and validated in BI’s pipeline The focus of the agreement is to enhance BI’s drug discovery pipeline utilizing PhoreMost’s PROTEINi and SITESEEKER platform […]Read More